The manufacturer of Ozempic and Wegovy, Novo Nordisk, states that semaglutide reaches a steady level in the bloodstream after about 4-5 weeks of use, so you might notice a change in appetite by then
Similarly, in metabolic dysfunction-associated steatotic liver disease (MASLD), GLP-1R agonists resolve hepatic steatosis by promoting healthy MERCS dynamics, thereby optimizing fatty acid oxidation (Lee et al., 2012) ( Figure 2 )
The mechanism by which Semaglutide GLP-1 reduces belly fat is not fully understood, but it may be related to its effects on appetite and satiety, as well as its ability to improve insulin sensitivity and glucose uptake by muscle and fat tissues
Watch television, listen to a podcast, or have a conversation while injecting
You will remain at this maintenance dose unless you experience any adverse side effects, in which case you may drop back down to 0.5 mg